Tin tức & Cập nhật

CV risk remains elevated in metabolically healthy obese
CV risk remains elevated in metabolically healthy obese
08 Oct 2021 bởiRoshini Claire Anthony

Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.

CV risk remains elevated in metabolically healthy obese
08 Oct 2021
Ketone supplements may promote better brain health in obese adults
Ketone supplements may promote better brain health in obese adults
08 Oct 2021
Antiviral monoclonal antibody therapies may prevent hospitalization in nonsevere COVID-19
Antiviral monoclonal antibody therapies may prevent hospitalization in nonsevere COVID-19
08 Oct 2021
Long-term KEEPsAKE data show sustained improvements with risankizumab for PsA
Long-term KEEPsAKE data show sustained improvements with risankizumab for PsA
08 Oct 2021 bởiAudrey Abella

The humanized immunoglobulin G1 monoclonal antibody risankizumab conferred long-term benefit for individuals with active psoriatic arthritis (PsA) who had inadequate responses to biologic and conventional synthetic DMARDs* (csDMARDs), according to the open-label extension (OLE) phase findings of the KEEPsAKE 1 and 2 trials presented at EADV 2021.

Long-term KEEPsAKE data show sustained improvements with risankizumab for PsA
08 Oct 2021